Surgeons who also conduct important biomedical research are struggling to obtain research funding, and that “broken pipeline” could spell extinction for surgeon-scientists and slow innovations for patients if something isn’t done, a team of UVA Health experts warns.
German ADC biotech Tubulis raises $138M to enter the clinic and expand in US
Munich-based Tubulis has brought in prominent European and US investors to back its work in antibody-drug conjugates, which have taken oncology R&D by storm. The
March 15, 2024